Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Elemer Piros

    Stock Analyst at Rodman & Renshaw

    (0.83)
    # 2401
    Out of 5,393 analysts
    142
    Total ratings
    Success rate
    Average return
    Main Sectors:
    Healthcare Financial Services
    Top Industries:
    Biotechnology Medical - Care Facilities Drug Manufacturers - Specialty & Generic
    49 Stocks
    Name Action PT Current % Upside Ratings Updated
    BTAI BioXcel Therapeutics
    Initiates Coverage On: Buy
    65
    		1.95 3233.33% 1 Mar 19, 2025
    FBLG FibroBiologics
    Initiates Coverage On: Buy
    12
    		0.62 1835.48% 1 Dec 12, 2024
    THAR Tharimmune
    Initiates Coverage On: Buy
    17
    		1.79 849.72% 1 Dec 6, 2024
    QNCX Quince Therapeutics
    Initiates Coverage On: Buy
    11
    		1.57 600.64% 1 Oct 29, 2024
    MNPR Monopar Therapeutics
    Initiates Coverage On: Buy
    50
    		35.35 41.44% 6 Oct 11, 2024
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Initiates Coverage On: Buy
    17
    		1.18 1340.68% 1 Sep 30, 2024
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Initiates Coverage On: Buy
    22
    		n/a n/a 1 Aug 19, 2024
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Reiterates: Buy
    107 107
    		2.03 5170.94% 1 Aug 8, 2024
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Reiterates: Buy
    14 14
    		n/a n/a 1 Jul 2, 2024
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Reiterates: Buy
    67 67
    		2.44 2645.9% 1 Jul 2, 2024
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Initiates Coverage On: Buy
    43
    		2.37 1714.35% 1 Jun 21, 2024
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Initiates Coverage On: Buy
    18
    		5.87 206.64% 7 Jun 13, 2024
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Buy
    12 8
    		1.19 530.25% 3 Sep 14, 2023
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Reiterates: Buy
    15 15
    		2.67 461.8% 8 Aug 9, 2023
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Reiterates: Buy
    21
    		7.15 193.71% 8 Aug 4, 2023
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Reiterates: Buy
    38
    		3.26 1065.64% 9 Aug 3, 2023
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Reiterates: Buy
    40
    		0.74 5305.41% 2 Jul 10, 2023
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Reiterates: Buy
    50
    		4.44 1026.13% 5 Jun 30, 2023
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Reiterates: Buy
    114
    		7.85 1352.23% 3 Jun 20, 2023
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Buy
    260 200
    		3.95 4963.29% 6 Jun 20, 2023
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Reiterates: Buy
    23
    		3.41 574.49% 2 May 16, 2023
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Reiterates: Buy
    33
    		14.91 121.33% 3 Mar 2, 2023
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Reiterates: Buy
    11
    		1.12 882.14% 2 Feb 14, 2023
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Downgrades: Sell
    40
    		17.99 122.35% 7 Apr 14, 2022
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Upgrades: Buy
    40
    		n/a n/a 3 Jan 4, 2022
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Initiates Coverage On: Buy
    37
    		1.56 2271.79% 1 Dec 1, 2021
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Buy
    38 32
    		3.67 771.93% 2 Jun 30, 2021
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Buy
    128 124
    		n/a n/a 7 May 6, 2021
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Initiates Coverage On: Buy
    10
    		n/a n/a 1 Apr 28, 2021
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Downgrades: Sell
    77
    		13.6 466.18% 2 Dec 23, 2020
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Initiates Coverage On: Buy
    70
    		0.67 10347.76% 1 Oct 12, 2020
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Initiates Coverage On: Buy
    240
    		n/a n/a 1 Sep 17, 2020
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Downgrades: Neutral
    n/a
    		n/a n/a 5 Sep 8, 2020
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Overweight
    21 24
    		1.3 1746.15% 4 May 28, 2020
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Overweight
    225 75
    		n/a n/a 2 May 12, 2020
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Neutral
    24 50
    		16.8 197.62% 5 Nov 19, 2019
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Assumes: Overweight
    33
    		4.17 691.37% 2 Oct 22, 2019
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Reiterates: Overweight
    191 186
    		19 878.95% 4 Aug 8, 2019
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Upgrades: Overweight
    n/a
    		n/a n/a 3 Jul 11, 2019
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Initiates Coverage On: Overweight
    26
    		3.09 741.42% 3 May 6, 2019
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Downgrades: Neutral
    80 115
    		n/a n/a 3 Feb 25, 2019
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Initiates Coverage On: Overweight
    21
    		n/a n/a 1 Nov 7, 2018
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Initiates Coverage On: Overweight
    28
    		142.43 -80.34% 1 Sep 11, 2018
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Overweight
    14 17
    		2 750% 2 Aug 9, 2018
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Overweight
    70 65
    		11.1 485.59% 2 Jun 13, 2018
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Overweight
    525 850
    		5.82 14504.81% 1 Oct 12, 2017
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Overweight
    204 84
    		n/a n/a 2 Sep 22, 2017
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Initiates Coverage On: Overweight
    29
    		n/a n/a 1 Jul 20, 2017
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Maintains: Overweight
    35 21
    		9.69 116.72% 2 Jul 12, 2017